APA (7th ed.) Citation

Jeroen Pollet, Wen-Hsiang Chen, Leroy Versteeg, Brian Keegan, Bin Zhan, Junfei Wei, . . . Maria Elena Bottazzi. (2021). SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Jeroen Pollet, et al. SARS‑CoV-2 RBD219-N1C1: A Yeast-expressed SARS-CoV-2 Recombinant Receptor-binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice. Taylor & Francis Group, 2021.

MLA (9th ed.) Citation

Jeroen Pollet, et al. SARS‑CoV-2 RBD219-N1C1: A Yeast-expressed SARS-CoV-2 Recombinant Receptor-binding Domain Candidate Vaccine Stimulates Virus Neutralizing Antibodies and T-cell Immunity in Mice. Taylor & Francis Group, 2021.